| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/04/2009 | US20090143283 Pituitary Adenylate Cyclase Activating Peptide (PACAP) Receptor (VPAC2) Agonists and Their Pharmacological Methods of Use |
| 06/04/2009 | US20090143248 Biologically active C-terminal arginine-containing peptides |
| 06/04/2009 | US20090143247 Methods for Producing Active scFv Antibodies and Libraries Therefor |
| 06/04/2009 | US20090142855 Polynucleotides and Polypeptides of the IL-12 Family of Cytokines |
| 06/04/2009 | US20090142801 butyrophilin-like nucleic acids; for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen |
| 06/04/2009 | US20090142800 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142784 Methods |
| 06/04/2009 | US20090142783 Human p51 Genes and Gene Products Thereof |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142777 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 06/04/2009 | US20090142776 Antibody for assaying adamts13 activity and method for assaying the activity |
| 06/04/2009 | US20090142768 Perforin-2 proteins |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies |
| 06/04/2009 | US20090142358 Human antibodies specific to kdr and uses thereof |
| 06/04/2009 | US20090142357 Specific Depletion of CD4+ T Cells |
| 06/04/2009 | US20090142356 Pharmaceutical Composition of F(ab')2 Antibody Fragments and a Process for the Preparation Thereof |
| 06/04/2009 | US20090142354 Human antibodies to human delta like ligand 4 |
| 06/04/2009 | US20090142353 Human Tumor Necrosis Factor Receptor TR17 |
| 06/04/2009 | US20090142352 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 06/04/2009 | US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 06/04/2009 | US20090142350 Pancreatic Cancer Genes |
| 06/04/2009 | US20090142349 CD19 Antibodies And Their uses |
| 06/04/2009 | US20090142348 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 06/04/2009 | US20090142346 Preventive/Remedy for Cancer |
| 06/04/2009 | US20090142345 Prophylactic/therapeutic agent for cancer |
| 06/04/2009 | US20090142343 Anti-VEGF antibodies |
| 06/04/2009 | US20090142341 Mutated pseudomonas exotoxins with reduced antigenicity |
| 06/04/2009 | US20090142340 Optimized Fc Variants and Methods for Their Generation |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | US20090142294 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 06/04/2009 | US20090142263 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 06/04/2009 | US20090142262 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer |
| 06/04/2009 | US20090142261 EPHB3-Specific Antibody and Uses Thereof |
| 06/04/2009 | CA2706675A1 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 06/04/2009 | CA2706633A1 Novel cancer-associated antibody and antigen |
| 06/04/2009 | CA2706583A1 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 06/04/2009 | CA2706479A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | CA2706476A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 06/04/2009 | CA2706425A1 Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| 06/04/2009 | CA2706419A1 Antigen-binding constructs |
| 06/04/2009 | CA2706403A1 Immunoglobulin aggregates |
| 06/04/2009 | CA2706300A1 Human monoclonal nicotine specific antibodies |
| 06/04/2009 | CA2706200A1 Immunoglobulin constructs |
| 06/04/2009 | CA2705890A1 Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| 06/04/2009 | CA2705879A1 Wise binding agents and epitopes |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065402A1 Trimeric collagen scaffold antibodies |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065399A1 The present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 06/03/2009 | EP2065398A1 Human monoclonal nicotine specific antibodies |
| 06/03/2009 | EP2065396A1 Interleukin-19 |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2065050A1 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 06/03/2009 | EP2065037A1 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx) |
| 06/03/2009 | EP2064551A2 Combination hepatitis c virus antigen and antibody detection method |
| 06/03/2009 | EP2064334A2 Aldehyde tags, uses thereof in site-specific protein modification |
| 06/03/2009 | EP2064325A2 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 06/03/2009 | EP2064246A2 Use of il-23 antagonists for treatment of infection |
| 06/03/2009 | EP2064245A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 06/03/2009 | EP2064244A2 ANTIBODIES DIRECTED TO alphaVß6 AND USES THEREOF |
| 06/03/2009 | EP2064243A2 Antagonistic human light-specific human monoclonal antibodies |
| 06/03/2009 | EP2064242A1 Engineered anti-il-23p19 antibodies |
| 06/03/2009 | EP2064241A2 Anti-il-6 monoclonal antibodies and uses thereof |
| 06/03/2009 | EP2064240A2 Optimized antibodies that target hm1.24 |
| 06/03/2009 | EP2064239A2 Anti-activin a antibodies and uses thereof |
| 06/03/2009 | EP2064231A1 Immunoreactive glycoprotein gp19 of ehrlichia canis |
| 06/03/2009 | EP1781328A4 Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby |
| 06/03/2009 | EP1769250B1 Immunoassay for determining the release of neurotensin into the circulation |
| 06/03/2009 | EP1660135B1 Method of treating hepatocellular carcinoma |
| 06/03/2009 | EP1407017B1 Human tumor necrosis factor receptor |
| 06/03/2009 | EP1295943B1 Polypeptides having activity of stimulating neutrophils |
| 06/03/2009 | EP1237926B1 Human antibodies as detection reagents |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | EP1111054B1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | EP0985032B2 Ribosome complexes as selection particles for in vitro display and evolution of proteins |
| 06/03/2009 | CN101448858A Combinatorial therapy involving alpha5beta1 antagonists |
| 06/03/2009 | CN101448857A Methods for preventing and treating amyloidogenic diseases |
| 06/03/2009 | CN101448856A Diagnostics and treatments for tumors |
| 06/03/2009 | CN101448855A Antibodies specific for Bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 06/03/2009 | CN101448854A Fusion protein comprising an Fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response |
| 06/03/2009 | CN101448853A Stabilized polypeptide compositions |
| 06/03/2009 | CN101446590A Methods for the identification of polypeptide antigens |
| 06/03/2009 | CN101445800A T1r taste receptors and genes encoding same |
| 06/03/2009 | CN101445558A monoclonal antibody of glycinin and application thereof |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/02/2009 | US7541513 Mouse λ light chain locus |
| 06/02/2009 | US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening |
| 06/02/2009 | US7541442 Antibodies and related molecules that bind to PSCA proteins |
| 06/02/2009 | US7541441 Antibodies that specifically bind to TL5 |
| 06/02/2009 | US7541440 Invention provides monoclonal antibody or fragment thereof that binds granulocyte (neutrophil) antigen, preferably provides humanized, chimeric and human anti-granulocyte-targeting antibodies, such as MN3 antibodies, useful for treatment and diagnosis of malignancy diseases resulting from ischemic injury |
| 06/02/2009 | US7541438 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| 06/02/2009 | US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 06/02/2009 | US7541330 Conjugates with reduced adverse systemic effects |
| 06/02/2009 | US7541184 Activation and expansion of cells |